| Date | Title | Description |
| 12.09.2024 | iClick Interactive's Strategic Shift: A New Chapter in Business Focus | In the bustling world of digital marketing, companies often find themselves at a crossroads. iClick Interactive Asia Group Limited, a prominent player in China's marketing cloud landscape, is currently navigating such a juncture. The compan... |
| 11.09.2024 | iClick Interactive Asia Group Limited Announces Execution of Definitive Agreement for Disposal of Its Demand Side Marketing Solutions Business in Mainland China | HONG KONG, Sept. 11, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 11.09.2024 | iClick Interactive Asia Group Limited Announces Execution of Definitive Agreement for Disposal of Its Demand Side Marketing Solutions Business in Mainland China | HONG KONG, Sept. 11, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 11.09.2024 | iClick Interactive Asia Group Limited Schedules 2024 Annual General Meeting for September 30, 2024 | HONG KONG, Sept. 11, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 04.09.2024 | Intensity Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference | SHELTON, Conn., Sept. 4, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies... |
| 06.08.2024 | Alimera Sciences Reports Second Quarter 2024 Results | Net Revenue up 54% to $27 Million vs. Q2 2023
Global End User Demand up 6% vs. Q2 2023
Company Recently Announced Definitive Merger Agreement with ANI Pharmaceuticals, Inc.
ATLANTA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (... |
| 19.07.2024 | iClick Interactive Asia Group Limited Announces Disposal of Its Mainland China Enterprise Solutions Business | HONG KONG, July 19, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 09.07.2024 | Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma | Testing the efficacy and safety of our lead product candidate, INT230-6, as Monotherapy Compared with Systemic U.S. Standard-of-Care Chemotherapy
SHELTON, Conn., July 9, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity&quo... |
| 24.06.2024 | iClick Interactive Asia Group Limited Announces Change to Its Board of Directors | HONG KONG, June 24, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 21.06.2024 | iClick Interactive Asia Group Limited Files 2023 Annual Report on Form 20-F | HONG KONG, June 20, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 04.06.2024 | Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal he... |
| 22.05.2024 | iClick Interactive Asia Group Limited Receives NASDAQ Deficiency Notice For Failure to Timely File Form 20-F | HONG KONG, May 22, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with ful... |
| 22.05.2024 | iClick Interactive Asia Group Limited Receives NASDAQ Deficiency Notice For Failure to Timely File Form 20-F | HONG KONG, May 22, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with ful... |
| 07.05.2024 | Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences | ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintainin... |
| 26.04.2024 | iClick Interactive Asia Group Limited Announces Termination of Merger Agreement | HONG KONG, April 26, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 28.03.2024 | iClick Appoints Ms. Josephine Ngai as Chief Financial Officer | HONG KONG, March 28, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 08.03.2024 | iClick Interactive Asia Group Limited Announces Shareholders' Approval of Merger Agreement | HONG KONG, March 8, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 02.02.2024 | iClick Interactive Asia Group Limited to Hold Extraordinary General Meeting of Shareholders | HONG KONG, Feb. 2, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with ful... |
| 13.12.2023 | iClick Interactive Asia Group Limited Reports 2023 Half-Year Unaudited Financial Results | HONG KONG, Dec. 13, 2023 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (Nasdaq: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 29.11.2023 | iClick Interactive Asia Group Limited Schedules 2023 Annual General Meeting for December 29, 2023 | HONG KONG, Nov. 29, 2023 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 24.11.2023 | iClick Interactive Asia Group Limited Enters into a Definitive Merger Agreement for Going-Private Transaction | HONG KONG, Nov. 24, 2023 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 24.08.2023 | iClick Interactive Bolsters Partnership with Xiaohongshu to Capture Overseas Opportunities | HONG KONG, Aug. 24, 2023 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 27.06.2023 | Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association’s Annual Conference | /EIN News/ -- FARMINGTON HILLS, Mich., June 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the ... |
| 26.01.2023 | NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Profusa, Inc. | New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- NorthView Acquisition Corp NVAC ("NorthView"), a publicly-traded special purpose acquisition company, and Profusa, Inc. ("Profusa"), a digital health company that is pionee... |
| 20.01.2023 | iClick Interactive Asia Group Limited Announces Engagement of Financial Advisor and Legal Counsel to Evaluate the Proposal | HONG KONG, Jan. 20, 2023 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 28.12.2022 | iClick Interactive Asia Announces US$5 Million Share Repurchase Program | HONG KONG, Dec. 28, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 08.12.2022 | Alimera Sciences Announces Agreement to Extend Amortization Date and Interest-Only Period on Loan Agreement | /EIN News/ -- ATLANTA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal healt... |
| 30.11.2022 | iClick Interactive Regains Compliance with Nasdaq's Minimum Bid Price Requirement | HONG KONG, Nov. 30, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 21.11.2022 | Ocuphire to Present at Five Upcoming Investor/Industry Conferences | /EIN News/ -- FARMINGTON HILLS, Mich., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of re... |
| 04.11.2022 | Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update | /EIN News/ -- NDA Submission for Nyxol for RM and Initiation of VEGA-2 on Track for Q4 2022
Topline Data from ZETA-1 Phase 2b Trial of Oral APX3330 Expected in Early 2023
FARMINGTON HILLS, Mich., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Ocuphire P... |
| 03.11.2022 | Manitex International Reports Third Quarter 2022 Results | BRIDGEVIEW, IL / ACCESSWIRE / November 3, 2022 / Manitex International, Inc. (Nasdaq:MNTX) ("Manitex" or the "Company"), a leading international provider of truck cranes, specialized industrial equipment, and constructio... |
| 11.10.2022 | Staffing 360 Solutions Announces the Re-Branding of Headway Workforce Solutions | NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United... |
| 10.10.2022 | Digital Health Acquisition Corp. Announces Filing of a Preliminary Extension Proxy Statement for a Stockholder Meeting on October 20, 2022 | BOCO RATON, FL / ACCESSWIRE / October 10, 2022 / Digital Health Acquisition Corp. (the "Company" or "Digital Health") (NASDAQ:DHAC), today announces the filing of a definitive proxy statement to hold a special meeting of... |
| 20.09.2022 | Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland | ATLANTA, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintai... |
| 25.08.2022 | iClick Interactive Asia Group Limited Reports 2022 Second-Quarter Unaudited Financial Results | - Enterprise Solutions revenue achieves modest growth despite lockdown measures in China –
- Enterprise Solutions revenue contribution hit a historic high of 36% –
HONG KONG, Aug. 25, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limit... |
| 09.08.2022 | Manitex International Reports Second Quarter 2022 Results | BRIDGEVIEW, IL / ACCESSWIRE / August 9, 2022 / Manitex International, Inc. (Nasdaq:MNTX) ("Manitex" or the "Company"), a leading international provider of truck cranes, specialized industrial equipment, and construction ... |
| 27.07.2022 | Alimera Sciences Announces Second Quarter 2022 Financial Results | Consolidated Net Product Revenue of $14.6 Million up 36% vs. Second Quarter of 2021
U.S. End User Demand up 45% vs. Second Quarter of 2021
International Segment End User Demand Up 21% vs. Second Quarter of 2021
ATLANTA, July 27, 2022 (GLOBE... |
| 13.07.2022 | ContraFect Announces Independent DSMB Recommends Exebacase Phase 3 DISRUPT Study Be Stopped for Futility Following Interim Analysis | YONKERS, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical mod... |
| 29.06.2022 | Manitex International Announces Commencement of Deliveries on $15 Million Order for Aerial Work Platforms to Enel S.p.A. | Promotes Giovanni Tacconi to Managing Director, Manitex Italy, and General Manager of PM Oil & Steel and Valla
BRIDGEVIEW, IL / ACCESSWIRE / June 29, 2022 / Manitex International, Inc. (NASDAQ:MNTX), a leading international provider of ... |
| 15.06.2022 | iClick Interactive Receives Minimum Bid Price Notice from Nasdaq | HONG KONG, June 15, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or "the Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 14.06.2022 | Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections | YONKERS, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 06.06.2022 | ContraFect to Present Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Combat MRSA at ASM Microbe 2022 | YONKERS, N.Y., June 06, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 06.06.2022 | Michael Coffey Named to Manitex International Inc.'s Board of Directors | BRIDGEVIEW, IL / ACCESSWIRE / June 6, 2022 / Manitex International, Inc. (NASDAQ:MNTX), a leading international provider of cranes and specialized industrial equipment, today announced that Michael Coffey, the Company's Chief Executive Offi... |
| 02.06.2022 | Alimera Sciences to Present at the LD Micro Invitational XII Conference | ATLANTA, June 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintain... |
| 27.05.2022 | Aesther Healthcare Acquisition Corp. and United Gear & Assembly, Inc. (High Precision Gears for Electric Vehicles) Announce Definitive Merger Agreement | Combined Company Expected to Trade on the NASDAQ Post-close under Ticker Symbol EVGT
NEW YORK, NY / ACCESSWIRE / May 27, 2022 / Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA) ("Aesther"), a special purpose acquisition company ... |
| 25.05.2022 | Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS | The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing funding specifically in the Development of KLS-13019 for Neuropathic Pain
DOYLESTOWN, PA / ACCESSWIRE / May... |
| 16.05.2022 | ContraFect Reports First Quarter 2022 Financial Results and Provides Business Update | YONKERS, N.Y., May 16, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides,... |
| 13.05.2022 | Zentek Announces Sales and Distribution of ZenGUARD(TM) Masks through Mark’s in Canada | GUELPH, ON / ACCESSWIRE / May 13, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that Mark's, a member of the Canadia... |
| 09.05.2022 | Alimera Sciences Reports First Quarter 2022 Results | Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021
U.S. Net Revenue Increased 23% vs. First Quarter of 2021
U.S. End User Demand Up 25% vs. First Quarter of 2021
ATLANTA, May 09, 2022 (GLOBE NEWSWIRE) -- Alimera Scien... |
| 04.05.2022 | Manitex International Reports First Quarter 2022 Results | BRIDGEVIEW, IL / ACCESSWIRE / May 4, 2022 / Manitex International, Inc. (NASDAQ:MNTX) ("Manitex" or the "Company"), a leading international provider of cranes and specialized industrial equipment, today announced results... |
| 27.04.2022 | ContraFect Data Presentations at the 32nd Annual ECCMID Meeting Highlight the Potential of Engineered Lysin CF-370 to Improve Clinical Outcomes and Suppress Antimicrobial Resistance Compared to Antibi... | YONKERS, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptide... |
| 18.04.2022 | ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting | YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptide... |
| 12.04.2022 | Zentek Signs Supply Agreement with EkoMed Global Inc. to Manufacture ZenGUARD-enhanced PPE | GUELPH, ON / ACCESSWIRE / April 12, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces it has signed a definitiv... |
| 11.04.2022 | Zentek Announces Start of Phase Two Testing of ZenGUARD(TM) - Coated Filters Under ISC Testing Stream Contract | GUELPH, ON / ACCESSWIRE / April 11, 2022 / further to its press release dated November 30, 2021, Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a Canadian intellectual property development and commerci... |
| 06.04.2022 | Alimera Exhibits Continued Growth and Expansion With New Branding and Office Relocation | ATLANTA, April 06, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintai... |
| 24.03.2022 | Zentek's ZenGUARD(TM) Patent Application Publishes | GUELPH, ON / ACCESSWIRE / March 24, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, is pleased to announce that its in... |
| 24.03.2022 | ContraFect Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Update | YONKERS, N.Y., March 24, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptide... |
| 21.03.2022 | ContraFect to Present at the Maxim Group 2022 Virtual Growth Conference | YONKERS, N.Y., March 21, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptide... |
| 14.03.2022 | iClick Announces to Fully Acquire Changyi | HONG KONG, March 14, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with f... |
| 24.02.2022 | Alimera Sciences Reports Fourth Quarter and FY 2021 Results | Fourth Quarter Highlights: Consolidated Net Revenue of $14 Million Up 15% vs. Third Quarter of 2021; Up 1% vs. Fourth Quarter of 2020
Full Year 2021 Highlights:
Consolidated Net Revenue of $59 Million Up 16% vs 2020
Consolidated Net Product... |
| 23.02.2022 | Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology | Best corrected visual acuity and central subfield thickness were significantly improved at 36 months
ILUVIEN treatment resulted in a 70.5% reduction in treatment burden
Results confirm that use of prior corticosteroid per the U.S. label mit... |
| 16.02.2022 | iClick Interactive Asia Group Limited Issues Letter to Shareholders and Provides Corporate Update | BEIJING, Feb. 16, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full... |
| 12.02.2022 | Amesite Announces Proposed Public Offering of Common Stock | DETROIT, Feb. 11, 2022 /PRNewswire/ -- Amesite Inc. (Nasdaq: AMST), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, nonprofit, and government ... |
| 12.02.2022 | Amesite Announces Pricing of Public Offering of Common Stock | DETROIT, Feb. 11, 2022 /PRNewswire/ -- Amesite Inc. (Nasdaq: AMST) ("Amesite" or the "Company"), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services fo... |
| 11.02.2022 | Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update | SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced... |
| 10.02.2022 | ContraFect to Present at the SVB Leerink 11th Annual Global Healthcare Conference | YONKERS, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 02.02.2022 | Amesite Becomes a Microsoft Customer Story | DETROIT, Feb. 2, 2022 /PRNewswire/ -- Amesite Inc. (Nasdaq: AMST), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, nonprofit, and government a... |
| 25.01.2022 | iClick Appoints Mr. David Zhang as Chief Financial Officer and Board Director | HONG KONG, Jan. 25, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited, (NASDAQ: ICLK, "iClick" or the "Company"), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 20.01.2022 | Amesite Announces Partnership with Cathie Wood's Innovation Foundation | DETROIT, Jan. 20, 2022 /PRNewswire/ -- Amesite Inc. (Nasdaq: AMST), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, nonprofit, and government ... |
| 19.01.2022 | Amesite to Present at Benzinga All Access on January 21, 2022 | DETROIT, Jan. 19, 2022 /PRNewswire/ -- Amesite Inc. (NASDAQ: AMST), the leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and govern... |
| 12.01.2022 | Kintara Announces Grant from Luxembourg National Research Fund and Cancer Foundation Luxembourg to Support VAL-083's Mechanism of Action Research in Glioblastoma | SAN DIEGO, Jan. 12, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced... |
| 07.01.2022 | ContraFect Announces Award from the Cystic Fibrosis Foundation to Evaluate Exebacase as a Potential Treatment for Serious MRSA Lung Infections Associated with Cystic Fibrosis | YONKERS, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 06.01.2022 | Zentek Ltd. Discusses C$33 Million Financing and 2022 Goals with The Stock Day Podcast | Phoenix, Arizona--(Newsfile Corp. - January 6, 2022) - The Stock Day Podcast welcomed Zentek Ltd. (OTC Pink: ZENYF) ("the Company"), an IP development and commercialization company focused on next-gen healthcare solutions in the a... |
| 06.01.2022 | ContraFect Announces Award from the Cystic Fibrosis Foundation to Evaluate Exebacase as a Potential Treatment for Serious MRSA Lung Infections Associated with Cystic Fibrosis | YONKERS, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 04.01.2022 | Zentek Announces Closing of C$23 Million Bought Deal Public Offering and C$10 Million Non-Brokered Private Placement, for Aggregate Proceeds of C$33 Million | Guelph, Ontario--(Newsfile Corp. - January 4, 2022) - Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company") a Canadian, IP development and commercialization company focused on next-gen healthcare solutions is ple... |
| 24.12.2021 | Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing | Guelph, Ontario--(Newsfile Corp. - December 23, 2021) - Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) ("ZEN" or the "Company"), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, ann... |
| 22.12.2021 | iClick Interactive Asia Announces $20 Million Share Repurchase Program | HONG KONG, Dec. 22, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 22.12.2021 | iClick Interactive Asia Announces $20 Million Share Repurchase Program | HONG KONG, Dec. 22, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 20.12.2021 | Compassionate Use Case Study Demonstrating the Potential of Investigational Direct Lytic Agent Exebacase to Treat MRSA Bacteremia in Pediatric Populations Published in Clinical Infectious Diseases | YONKERS, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 07.12.2021 | Amesite Inc. to Present at Sidoti Virtual Investor Conference December 8-9, 2021 | DETROIT, Dec. 7, 2021 /PRNewswire/ -- Amesite Inc. (NASDAQ: AMST), the leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and governm... |
| 02.12.2021 | BioHiTech Global to Present at the Sequire Clean Tech & EV Virtual Conference on December 6, 2021 | CHESTNUT RIDGE, N.Y., Dec. 2, 2021 /PRNewswire/ -- BioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ: BHTG), a sustainable technology and services company, announces today that Chief Executive Officer Tony Fu... |
| 30.11.2021 | Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma | SAN DIEGO, Nov. 30, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced... |
| 30.11.2021 | Amesite to Present at Zooming with LD Micro on December 1, 2021 | DETROIT, Nov. 30, 2021 /PRNewswire/ -- Amesite Inc. (NASDAQ: AMST), the leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and govern... |
| 30.11.2021 | iClick Interactive Asia Group Limited Reports 2021 Third-Quarter Unaudited Financial Results | - Enterprise Solutions achieves eighth consecutive quarter of record results -
- Marketing Solutions revenue grows 11% year-over-year to US$67 million -
HONG KONG, Nov. 30, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("i... |
| 22.11.2021 | iClick Interactive Asia Group Limited Schedules 2021 Annual General Meeting for December 22, 2021 | HONG KONG, Nov. 22, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 17.11.2021 | Amesite to Provide Video Shareholder Update on November 18, 2021 at 5:00PM ET | DETROIT, Nov. 17, 2021 /PRNewswire/ -- Amesite Inc. (NASDAQ: AMST), the leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and govern... |
| 16.11.2021 | iClick Interactive to Report Third Quarter 2021 Financial Results on November 30, 2021 | HONG KONG, Nov. 16, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or "the Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 15.11.2021 | Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update | SAN DIEGO, Nov. 15, 2021 /PRNewswire/ -- https://www.kintara.com/ (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced f... |
| 15.11.2021 | ContraFect Reports Third Quarter 2021 Financial Results and Provides Corporate Update | YONKERS, N.Y., Nov. 15, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 11.11.2021 | Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021 | SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announces today that its Chief Executive Officer, Robert E. Hoff... |
| 11.11.2021 | CETY Finalizes Acquisition of Jiangsu Huanya Jieneng New Energy Co. Allowing Penetration into China's Natural Gas Sector | COSTA MESA, Calif., Nov. 11, 2021 /PRNewswire/ -- Clean Energy Technologies, Inc. (OTCQB: CETY), a low-carbon energy company focusing on products and solutions in the energy efficiency and environmental sustainability market, announces toda... |
| 09.11.2021 | ContraFect’s New Data Presented at NACFC Demonstrate Potential of Direct Lytic Agents to Treat Pulmonary Infections in Patients with Cystic Fibrosis | YONKERS, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 09.11.2021 | Kintara Announces Changes to Executive Leadership Team | SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- https://www.kintara.com/ (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced th... |
| 05.11.2021 | Clean Energy Technologies Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services | COSTA MESA, Calif., Nov. 5, 2021 /PRNewswire/ -- Clean Energy Technologies (OTCQB: CETY), ("Clean Energy" or the "Company"), a low carbon energy company focusing on products and solutions in the energy efficiency and env... |
| 28.10.2021 | Alimera Sciences Announces Third Quarter 2021 Financial Results | Consolidated Net Revenue of $12.2 Million Down 2% vs. Third Quarter of 2020 and Up 14% vs. Second Quarter of 2021U.S. End User Demand up 15% vs. Third Quarter of 2020 and Second Quarter of 2021
ATLANTA, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Ali... |
| 28.10.2021 | Alimera Sciences Announces Third Quarter 2021 Financial Results | Consolidated Net Revenue of $12.2 Million Down 2% vs. Third Quarter of 2020 and Up 14% vs. Second Quarter of 2021U.S. End User Demand up 15% vs. Third Quarter of 2020 and Second Quarter of 2021
ATLANTA, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Ali... |
| 26.10.2021 | ContraFect to Present Data on the Potential of DLAs to Treat Pulmonary Infections in Cystic Fibrosis Patients | YONKERS, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides... |
| 21.10.2021 | iClick Interactive Asia Group Limited : Announces Formation of Special Committee and Engagement of Financial Adviser to Evaluate and Consider Prior Proposals or Any Alternative Strategic Option | HONG KONG, Oct. 21, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 21.10.2021 | iClick Interactive Asia Group Limited Announces Formation of Special Committee and Engagement of Financial Adviser to Evaluate and Consider Prior Proposals or Any Alternative Strategic Option | HONG KONG, Oct. 21, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
| 20.10.2021 | iClick's Cross-border SaaS Solutions iSmartGo Powers L'OCCITANE's Innovative O2O Strategy in China's Rapidly Growing Travel Retail Industry | HONG KONG, Oct. 20, 2021 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with fu... |
